Butterfly Network (BFLY) Debt to Equity (2020 - 2021)

Butterfly Network's (BFLY) quarterly Debt to Equity came in at $0.0 in Q3 2021, up 120.65% quarter-over-quarter from $0.0 in Q2 2021.

Butterfly Network (BFLY) Debt to Equity (2020 - 2021) Analysis & Trends

Butterfly Network has disclosed Debt to Equity across 2 years of filings, most recently posting $0.0 for Q3 2021.

Debt to Equity for Q3 2021 came in at $0.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2021 was $0.0 (changed N/A YoY), and the FY2020 annual result was -$0.01, changed N/A from the prior year.
Debt to Equity came in at $0.0 for Q3 2021 at Butterfly Network, up from $0.0 in the prior quarter.
In the past five years, Debt to Equity ranged from a high of $0.0 in Q1 2021 to a low of -$0.01 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt/Equity (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn	0.65
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn	0.64
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn	0.57
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn	0.42
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn	0.06
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn	0.95
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	0.71
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn	-
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn	0.27
10	Butterfly Network	1.42 Bn	1.28 Bn	18.29 Mn	-

Download Data